Genetic testing of leiomyoma tissue in women younger than 30 years old might provide an effective screening approach for the hereditary leiomyomatosis and renal cell cancer syndrome (HLRCC)

Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome–associated Renal Cancer

(2014) Ying-Bei Chen et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Potential genetic anticipation in hereditary leiomyomatosis-renal cell cancer (HLRCC)

(2014) Mei Hua Wong et al.   Familial Cancer

Fumarate hydratase immunohistochemical staining may help to identify patients with multiple cutaneous and uterine leiomyomatosis (MCUL) and hereditary leiomyomatosis and renal cell cancer (HLRCC) syndrome

(2014) M. Llamas-Velasco et al.   JOURNAL OF CUTANEOUS PATHOLOGY

The International Society of Urological Pathology (ISUP) Vancouver Classification of Renal Neoplasia

(2013) John R. Srigley et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Uterine smooth muscle tumors with features suggesting fumarate hydratase aberration: detailed morphologic analysis and correlation with S-(2-succino)-cysteine immunohistochemistry

(2013) Carolina Reyes et al.   MODERN PATHOLOGY

Morphologic and Molecular Characteristics of Uterine Leiomyomas in Hereditary Leiomyomatosis and Renal Cancer (HLRCC) Syndrome

(2012) Julian Sanz-Ortega et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

LOVD v.2.0: the next generation in gene variant databases

(2011) Ivo F. A. C. Fokkema et al.   HUMAN MUTATION

Aberrant succination of proteins in fumarate hydratase-deficient mice and HLRCC patients is a robust biomarker of mutation status

(2011) Chiara Bardella et al.   JOURNAL OF PATHOLOGY